Cargando…
Exenatide's effect in reducing weight and glycosylated hemoglobin level in an Arab population with type 2 diabetes
OBJECTIVES: To determine whether exenatide is effective in reducing weight and glycosylated hemoglobin level (HbA1c), and to investigate its efficacy in improving lipid profile, blood pressure, and creatinine levels in the Arab population. METHODS: This study was conducted at the Endocrine Unit, Dub...
Autores principales: | Bashier, Alaaeldin M., Abdelgadir, Elamin I., Khalifa, Azza A., Rashid, Fouzia, Abuelkheir, Sona M., Bachet, Fawzi E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Saudi Medical Journal
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362132/ https://www.ncbi.nlm.nih.gov/pubmed/25399222 |
Ejemplares similares
-
Peri-portal lymphedema in association with an acute adrenal insufficiency: case report
por: Abdelgadir, Elamin Ibrahim Elamin, et al.
Publicado: (2014) -
Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes
por: Bashier, Alaaeldin, et al.
Publicado: (2017) -
Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern
por: Alawadi, Fatheya, et al.
Publicado: (2019) -
Liraglutide effect in reducing HbA1c and weight in Arab population with type2 diabetes, a prospective observational trial
por: Bashier, Alaaeldin M. K., et al.
Publicado: (2015) -
SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018)